-
152022.11
[ESG] Signed 'Joint Business Agreement for Strategic Technology Commer..
Dear shareholders,SCM Lifescience, Inc.'s beginning is the ‘Inha University Hospital Adult Stem Cell Project Group', whi..
-
152022.11
[IR] September 28th SCM Lifescience inc. online company briefing FAQ
September 28, 2022, we will share the contents of the FAQ announced at this online company briefing session.1. FundingTh..
-
152022.11
[IR] Review of SCM Lifescience Inc. online company briefing session on..
That’s one small step for a man, one giant leap for mankind. -Neil Alden ArmstrongThe small challenge of humans started ..
-
152022.11
[IR] On September 28th, SCM Lifescience Inc. held an ‘online company b..
SCM Lifescience Inc. would like to hold an ‘online company briefing session’ as follows.1. Subject : Moderate-Severe Acu..
-
152022.11
[IR] SCM Lifescience ‘corporate meeting' held on September 5th
SCM Lifesciences Inc. will hold a corporate meeting to present the results of the Phase 2a clinical trial for moderate t..
-
152022.11
Statement from SCM Lifescience Inc. in response to a request for discl..
On August 31, SCM Lifescience Inc. completed the disclosure of the clinical results of acute pancreatitis phase 2a throu..
-
152022.11
[Open Innovation] Participated in Korea Society for Stem Cell Research..
For two days from August 11th to 12th, SCM Lifescience Inc. participated in the ‘Korea Society for Stem Cell Research An..
-
152022.11
SCM Lifescience Inc. CEO Byung-Kwan Son inauguration speech
Hello.I am Byung-Kwan Son, the 4th CEO of SCM Lifescience Inc.When SCM Lifescience offered to serve as the CEO, I was ve..
-
152022.11
2022 SCM Lifescience Extraordinary Shareholders’ Meeting Review
SCM Lifescience Inc. held an extraordinary general meeting of shareholders.We would like to thank the shareholders once ..